EcoDrugPlus

Ensembl ID : ENSOCUG00000038147
Gene Symbol: -
1 Cross references
34 Possible Orthologues:

Ensembl ID : ENSOCUG00000021700
Gene Symbol: -
1 Cross references
165 Possible Orthologues:

Ensembl ID : ENSOCUG00000017547
Gene Symbol: -
1 Cross references
294 Possible Orthologues:

Ensembl ID : ENSOCUG00000021974
Gene Symbol: -
1 Cross references
242 Possible Orthologues:

Ensembl ID : ENSOCUG00000038521
Gene Symbol: -
1 Cross references
40 Possible Orthologues:

Ensembl ID : ENSOCUG00000038725
Gene Symbol: -
1 Cross references
34 Possible Orthologues:

Ensembl ID : ENSOCUG00000039083
Gene Symbol: -
1 Cross references
151 Possible Orthologues:

Ensembl ID : ENSOCUG00000025687
Gene Symbol: -
1 Cross references
29 Possible Orthologues:

Ensembl ID : ENSOCUG00000035553
Gene Symbol: -
1 Cross references
100 Possible Orthologues:

Ensembl ID : ENSOCUG00000005039
Gene Symbol: -
1 Cross references
284 Possible Orthologues:

Ensembl ID : ENSOCUG00000022399
Gene Symbol: -
1 Cross references
267 Possible Orthologues:

Ensembl ID : ENSOCUG00000022401
Gene Symbol: -
1 Cross references
445 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).